Loading page
Loading page
Loading substance route
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
Demonstrates significantly higher abuse potential than morphine in human use, with compulsive redosing patterns similar to heroin. The rapid onset produces an intense euphoric rush that reinforces addictive behavior. Animal studies showed limited addiction liability, but real-world use patterns indicate extremely high psychological addiction potential.
Physical dependence develops with repeated administration, requiring increasing doses to achieve desired effects. Withdrawal syndrome occurs upon cessation. Animal studies in monkeys showed less severe tolerance and withdrawal compared to morphine, though human patterns indicate significant physical dependence typical of potent opioids.
As with most opioids, death can occur at high doses due to respiratory depression. The risk is substantially increased when combined with other CNS depressants. A significant number of deaths are caused by aspiration of vomit in unconscious users. Illicitly produced krokodil carries additional fatal risks from injection of toxic contaminants.
Pure desomorphine produces more severe respiratory depression than morphine at equianalgesic doses, making this the primary mechanism of fatal overdose.
Pure desomorphine can cause hypotension as a clinical side effect. Illicitly manufactured krokodil is associated with destruction of blood vessels, phlebitis, thrombosis, and endocarditis from injection of contaminated material.
Injection of contaminated krokodil causes immediate damage and destruction of skin, blood vessels, muscles, and bone, sometimes requiring limb amputation in long-term users; pure desomorphine does not cause these effects.
Illicit krokodil use is associated with bone infection (osteomyelitis), cartilage damage, and muscle destruction; these effects stem from toxic synthesis contaminants rather than desomorphine itself.
Liver damage has been reported in users of illicitly manufactured krokodil, attributed to toxic synthesis contaminants rather than desomorphine itself.
Kidney damage has been reported in users of illicitly manufactured krokodil, attributed to toxic contaminants rather than desomorphine itself.
Iodine used in illicit synthesis can cause thyroid damage in users of contaminated krokodil.
Brain damage has been reported among users of illicitly manufactured krokodil, attributed to toxic contaminants; pure desomorphine causes sedation but no documented long-term neurotoxicity.
Urinary retention is a recognized side effect at clinical doses and was considered a significant adverse effect limiting therapeutic use.
Seizures are listed among serious medical complications but are not a primary concern or commonly reported adverse effect with desomorphine use.
Desomorphine was first discovered and patented in Germany in 1920 by researchers working for the pharmaceutical company Knoll, though this early work did not gain widespread recognition. The compound was independently synthesized in the United States in 1932 by chemist Lyndon Frederick Small, who…
Single Convention on Narcotic Drugs 1961
Listed in Anlage I of the Betäubungsmittelgesetz (Narcotics Act). Manufacturing, importing, possessing, selling, or transferring the substance without a license is illegal.
Specifically named as a controlled substance under Verzeichnis A of Swiss narcotics regulations. Unlike many other jurisdictions, medicinal use is permitted under appropriate authorization.
Controlled as a Schedule I substance under Russian drug legislation. Possession, production, and distribution are prohibited.
Controlled under the Controlled Substances Act (USC Title 21). Manufacturing, buying, possessing, or distributing desomorphine without a DEA license is prohibited. Classified as a depressant with high abuse potential and no accepted medical use.
14 sources cited
